Skip to search.
 TSX Up 0.24% TSX Ventures Up 0.49%

Abbott Laboratories (ABT)

-NYSE
43.17 Up 0.13(0.30%) Jul 22, 4:00PM EDT
|After Hours : 43.19 Up 0.02 (0.05%) Jul 22, 4:56PM EDT
Prev Close:43.04
Open:43.05
Bid:42.23 x 300
Ask:43.21 x 100
1y Target Est:47.64
Beta:1.47633
Earnings Date:Oct 19 - Oct 24 (Est.)
Day's Range:42.81 - 43.26
52wk Range:36.00 - 51.24
Volume:10,205,059
Avg Vol (3m):11,535,400
Market Cap:63.42B
P/E (ttm):28.50
EPS (ttm):1.52
Div & Yield:1.04 (2.44%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ABTUp 0.30%63.42B

Key Statistics

Forward P/E (1 yr):17.62
P/S (ttm):3.08
Ex-Dividend Date:13-Jul-16

Analysts

Annual EPS Est (Dec-16) :2.20
Quarterly EPS Est (Sep-16) :0.58
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):2.11

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Abbott Laboratories manufactures and sells health care products worldwide. The company’s Established Pharmaceutical Products segment offers branded generic pharmaceuticals to treat pancreatic exocrine insufficiency; irritable bowel syndrome o... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback